Ipsen, a global biopharmaceutical company specializing in providing innovative solutions in oncology, rare diseases and neurology, appointed Arkadiusz Budzinski as CEO of Ipsen Poland sp. z o.o. in March.
Arkadiusz Budzinski, a graduate of the Faculty of Management at the EU in Poznan and postgraduate studies at the Faculty of Finance at the Warsaw School of Economics, brings to Ipsen Poland a wealth of financial, marketing and commercial experience gained in local, regional and global management positions at companies such as Unilever, Novartis, GS...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
